Remedent Stock Forecast for 2023 - 2025 - 2030

Updated on 04/26/2024

Stock Rating
0
Price Target
0.00
Consensus
-
Downside
-100.00%
Analysts
0
Stock Rating
0
Downside
-100.00%
Analysts
0
Price Target
0.00
-

Remedent Fair Value Forecast for 2023 - 2025 - 2030

In the last three years, Remedent's Price has grown by 100.00%, rising from 0.00 to 0.00. For next year, analysts predict Fair Value of 0.00, which would mean an increase of 100.00%. Over the next five years, experts predict that Remedent's Fair Value will grow at a rate of 100.00%.

2026 Fair Value Forecast
0.00
2027 Fair Value Forecast
0.00
2028 Fair Value Forecast
0.00
2029 Fair Value Forecast
0.00
2030 Fair Value Forecast
0.00

Remedent Revenue Forecast for 2023 - 2025 - 2030

In the last year, Remedent's Revenue has seen a drop from 1.06M to 50.00k – a 95.28% decrease. For next year, analysts predict Revenue of 1.06M, which would mean an increase of 2020.00%. Over the next seven years, experts predict that Remedent's Revenue will grow at a rate of 383675.45%.

2024 Rev Forecast
0.00B
2025 Rev Forecast
0.01B
2026 Rev Forecast
0.05B
2027 Rev Forecast
0.01B
2028 Rev Forecast
0.02B
2029 Rev Forecast
0.06B
2030 Rev Forecast
0.19B

Remedent Dividend per Share Forecast for 2023 - 2025 - 2030

Remedent Free Cash Flow Forecast for 2023 - 2025 - 2030

Remedent EBITDA Forecast for 2023 - 2025 - 2030

In the last year, Remedent's EBITDA has decreased from -410.00k to -260.00k – a 36.59% drop. In the next year, analysts believe that EBITDA will reach -409.99k – an increase of 57.69%. For the next seven years, experts predict that Remedent's EBITDA will grow at a rate of 53.80%.

2024 EBITDA Forecast
-409994.00
2025 EBITDA Forecast
-388851.98
2026 EBITDA Forecast
-423265.38
2027 EBITDA Forecast
-367859.94
2028 EBITDA Forecast
-383028.03
2029 EBITDA Forecast
-386820.01
2030 EBITDA Forecast
-399868.74

Remedent EBIT Forecast for 2023 - 2025 - 2030

In the last year, Remedent's EBIT has decreased by 41.67%, going from -480.00k to -280.00k. In the next year, analysts believe that EBIT will reach -480.00k – an increase of 71.43%. For the next seven years, the forecast is for EBIT to grow by 70.40%.

2024 EBIT Forecast
-480004.00
2025 EBIT Forecast
-460947.84
2026 EBIT Forecast
-513019.58
2027 EBIT Forecast
-431466.57
2028 EBIT Forecast
-449990.87
2029 EBIT Forecast
-456935.73
2030 EBIT Forecast
-477132.29

Remedent EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last three years, Remedent's EPS has grown by 100.00%, rising from 0.00 to 0.00. For next year, analysts predict EPS of 0.00, which would mean an increase of 100.00%. Over the next five years, experts predict that Remedent's EPS will grow at a rate of 100.00%.

2026 EPS Forecast
0.00
2027 EPS Forecast
0.00
2028 EPS Forecast
0.00
2029 EPS Forecast
0.00
2030 EPS Forecast
0.00